Fraunhofer Center for Molecular Biotechnology (FhCMB), a subsidiary of Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV is a research institute that conducts research and development in plant and microbial biotechnology. The institute's translational research concentrates on targets in the therapeutic, vaccine and antibody areas, which directly relate to public health and biopreparedness. It offers research and development services such as proof of concept, process development and scale-up, formulation development, analytical services, and preclinical evaluation. The institute identifies new microbes for industrial and medical applications. FhCMB is headquartered in Newark, Delaware, the US.
Fraunhofer Center for Molecular Biotechnology - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Market Overview: The global barrier materials market grew at a CAGR of around 6% during 2015-2020. Barrier materials refer to various packaging and enclosure solutions designed to minimize or prevent the permeability of gases, liquids or radiation. They are effective against oxygen, nitrogen,...
Healthcare Energy Management Systems Companies are revising their long-term strategies to emerge stronger in the post-COVID pandemic scenario. After facing series of challenges such as supply chain disruption, demand fluctuations, other pressing concerns during 2020, companies are revising their strategies through modifying the composition...
438 pages •
By Global Industry Analysts
• Apr 2021
- Cuts Backs On Capital Spending in the Wake of COVID-19 Thwarts All Hopes of Growth for Titrators. Market Slumps by -6%
- The global market for Titrators (Automatic and Manual) is expected to slump by -6% in the year 2020 and thereafter recover and grow to reach US$470.5 million by the year 2027, trailing...
The global generic oncology drugs market exhibited strong growth during 2015-2020. Generic oncology drugs assist in shrinking, controlling and destroying the cancer cells present in the human body. Furthermore, a few oncology drugs are widely prescribed by doctors to alleviate symptoms, including pain. They share the...
The Global Antibody Partnering Terms and Agreements 2014 to 2021 report provides comprehensive understanding and unprecedented access to the Antibody partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies...
The gaming accessories market is expected to reach a CAGR of 9.5% during the forecast period of 2021 - 2026. Increasing adoption of smartphones, rapidly evolving technologies such as virtual reality (VR) and artificial intelligence (AI) are fueling the growth of the market across the globe. - Major gaming console manufacturers like...
The global nurse call systems market is expected to reach US$ 3,243.34 million by 2027 from US$ 1,342.70 million in 2019. The market is estimated to grow at a CAGR of 11.5% from 2020 to 2027. Driving factors, such as increase in incidence of Alzheimer’s cases, rise in number of assisted living centers, and technological developments...
Forecasts by Device (Opto-Semiconductor Device, Power Semiconductor Device, RF Semiconductor Device), by Component (Transistor, Diode, Rectifier, Power IC, Others), by Wafer Size (2", 4", 6", 8"), by Applications (Radio Frequency, Power Diodes, Light Detection and Ranging), by Vertical (Automotive, Consumer Electronics, Defence &...
The global automated guided vehicles (AGV) market was valued at US$ 3,310.8 million in 2020 and is projected to reach US$ 9,077.3 million by 2028; it is expected to grow at a CAGR of 14.59% during 2021–2028. The adoption of automated guided vehicle (AGVs) has increased drastically as they are effective and reliable solutions for material...
The Global Infectious Vaccines Partnering Terms and Agreements 2014 to 2021: Deal trends, players and financials report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a right...
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.